Skip to main content
. 2016 May 23;36(1):79–89. doi: 10.3892/or.2016.4829

Figure 6.

Figure 6

Selective binding of the NYZL1 peptide to human bladder tumor tissues. Frozen sections of bladder cancer (A and B), normal bladder (C and D), breast cancer (E and F) and kidney cancer (G and H) tissues were incubated with 100 μmol/l FITC-NYZL1 or FITC-svNYZL1 (negative control) at 4°C for 1 h, and counterstained with DAPI. Fluorescent images of tissue slides were visualized under a fluorescence microscope. Images are merged for the fluorescent peptide and DAPI staining. Magnification, ×200. (I) Quantification of fluorescence intensity. The average intensities (integrated intensity/unit area) of fluorescence in the tumor (n=5) and normal tissues (n=3) were calculated.